3
Announcements
Trials
Browse
Landscape
Status
Recruiting
2
Active not recruiting
1
Sponsor Class
OTHER
3
Study Type
Interventional
9
Observational
3
Sponsor
Cancer Type
Tumor-Agnostic
1
Thoracic
1
Gynecologic
1
Gastrointestinal
1
Conditions
Uterine Cervical Neoplasms
1
Neoplasms
1
Lung Neoplasms
1
Liver Neoplasms
1
Hypoxia
1
Interventions
Surveys and Questionnaires
18
Blood Specimen Collection
16
Specimen Handling
12
Observation
6
Magnetic Resonance Spectroscopy
6
Surgical Procedures, Operative
5
Radiotherapy
5
trastuzumab deruxtecan
4
ribociclib
4
darolutamide
4
Standard of Care
4
Patient Reported Outcome Measures
4
Letrozole
4
Data Collection
4
Cryosurgery
4
Breath Tests
4
Tomography, X-Ray Computed
3
Radiation
3
Neoadjuvant Therapy
3
Magnetic Resonance Imaging
3
Biopsy
3
Anastrozole
3
lorlatinib
2
cemiplimab
2
atezolizumab
2
Ultrasonography
2
Trastuzumab
2
Staining and Labeling
2
Restraint, Physical
2
Positron-Emission Tomography
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
3 trials
Recent
Start date
Enrollment
Observational
×
Magnetic Resonance Imaging
×
30 days
×
Clear all
NCT05029258
2026-05-12
Bio-CHECC
University of Manchester
Active not recruiting
30 enrolled
NCT05427136
2026-05-08
SWISS-Pearl
University Children's Hospital Basel
Recruiting
140 enrolled
NCT04657042
2026-05-06
4D-MRI for Precision Medicine
University of Virginia
Recruiting
100 enrolled